skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Design and dosimetric considerations of a modified COMS plaque: The reusable 'seed-guide' insert

Journal Article · · Medical Physics
DOI:https://doi.org/10.1118/1.1993828· OSTI ID:20726283
; ;  [1]
  1. Department of Radiation Oncology, University of Southern California School of Medicine, Los Angeles, California 90033 (United States) and Department of Radiation Oncology, Saint Vincents Comprehensive Cancer Center, New York, New York 10011 (United States) and New York Eye Cancer Center and New York Eye and Ear Infirmary, St. Vincent's Comprehensive Cancer Center and New York University School of Medicine, New York, New York 10011 (United States)

The Collaborative Ocular Melanoma Study (COMS) developed a standardized set of eye plaques that consist of a 0.5 mm thick bowl-like gold alloy backing with a cylindrical collimating lip. A Silastic seed carrier into which {sup 125}I seeds are loaded was designed to fit within the backing. The carrier provides a standardized seed pattern and functions to offset the seeds by 1.0 mm from the concave (front) surface of the carrier. These Silastic carriers have been found to be difficult to load, preclude flash sterilization, and are a source of dosimetric uncertainty because the effective atomic number of Silastic is significantly higher than that of water. The main dosimetric effect of the Silastic carrier is a dose-reduction (compared to homogeneous water) of approximately 10%-15% for {sup 125}I radiation. The dose reduction is expected to be even greater for {sup 103}Pd radiation. In an attempt to improve upon, yet retain as much of the familiar COMS design as possible, we have developed a thin 'seed-guide' insert made of gold alloy. This new insert has cutouts which match the seed pattern of the Silastic carrier, but allows the seeds to be glued directly to the inner surface of the gold backing using either dental acrylic or a cyanoacrylate adhesive. When glued directly to the gold backing the seeds are offset a few tenths of a millimeter further away from the scleral surface compared to using the Silastic carrier. From a dosimetric perspective, the space formerly occupied by the Silastic carrier is now assumed to be water equivalent. Water equivalency is a desirable attribute for this space because it eliminates the dosimetric uncertainties related to the atomic composition of Silastic and thereby facilitates the use of either {sup 125}I and/or {sup 103}Pd seeds. The caveat is that a new source of dosimetric uncertainty would be introduced were an air bubble to become trapped in this space during or after the surgical insertion. The presence of air in this space is modeled and the dosimetric impact discussed. Another unintended consequence of water equivalency is that some fluorescent x rays emitted from the gold backing can now reach the eye. These very low energy x rays were virtually eliminated by absorption in Silastic. When loaded with {sup 125}I seeds the modified plaque appears to produce dose distributions that are almost the same as those of the original COMS plaque and the maximum dosimetric uncertainty introduced by an air bubble is about 2%. Dose distributions calculated for a modified plaque loaded with {sup 103}Pd seeds show that dose to healthy ocular structures distal to the tumor apex can be reduced compared to {sup 125}I. Clearly, it is faster and easier to glue seeds into the reusable gold seed-guide insert than it is to load the COMS-Silastic carrier.

OSTI ID:
20726283
Journal Information:
Medical Physics, Vol. 32, Issue 8; Other Information: DOI: 10.1118/1.1993828; (c) 2005 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA); ISSN 0094-2405
Country of Publication:
United States
Language:
English

Similar Records

Monte Carlo dosimetry for {sup 125}I and {sup 103}Pd eye plaque brachytherapy
Journal Article · Mon Dec 15 00:00:00 EST 2008 · Medical Physics · OSTI ID:20726283

Monte Carlo dosimetry for {sup 125}I and {sup 103}Pd eye plaque brachytherapy with various seed models
Journal Article · Fri Jan 15 00:00:00 EST 2010 · Medical Physics · OSTI ID:20726283

Improved treatment planning for COMS eye plaques
Journal Article · Tue Mar 15 00:00:00 EST 2005 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20726283